STENO Stock Overview
Stenocare A/S cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products to patients in the Danish and European markets.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Stenocare A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr.5.10 |
| 52 Week High | kr.8.80 |
| 52 Week Low | kr.2.27 |
| Beta | 0.20 |
| 1 Month Change | -26.30% |
| 3 Month Change | 108.16% |
| 1 Year Change | -40.42% |
| 3 Year Change | -67.43% |
| 5 Year Change | n/a |
| Change since IPO | -86.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| STENO | DK Pharmaceuticals | DK Market | |
|---|---|---|---|
| 7D | 18.6% | 3.2% | 2.3% |
| 1Y | -40.4% | 5.7% | 25.0% |
Return vs Industry: STENO underperformed the Danish Pharmaceuticals industry which returned 5.7% over the past year.
Return vs Market: STENO underperformed the Danish Market which returned 25% over the past year.
Price Volatility
| STENO volatility | |
|---|---|
| STENO Average Weekly Movement | 21.7% |
| Pharmaceuticals Industry Average Movement | 4.9% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in DK Market | 9.0% |
| 10% least volatile stocks in DK Market | 2.9% |
Stable Share Price: STENO's share price has been volatile over the past 3 months.
Volatility Over Time: STENO's weekly volatility has increased from 15% to 22% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | n/a | Thomas Schnegelsberg | www.stenocare.dk |
Stenocare A/S cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products to patients in the Danish and European markets. It offers medical cannabis oil products. Stenocare A/S was incorporated in 2017 and is based in Randers, Denmark.
Stenocare A/S Fundamentals Summary
| STENO fundamental statistics | |
|---|---|
| Market cap | kr.92.52m |
| Earnings (TTM) | -kr.17.57m |
| Revenue (TTM) | kr.3.99m |
23.2x
P/S Ratio-5.3x
P/E RatioIs STENO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| STENO income statement (TTM) | |
|---|---|
| Revenue | kr.3.99m |
| Cost of Revenue | kr.10.18m |
| Gross Profit | -kr.6.18m |
| Other Expenses | kr.11.38m |
| Earnings | -kr.17.57m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 02, 2024
| Earnings per share (EPS) | -0.97 |
| Gross Margin | -154.90% |
| Net Profit Margin | -440.03% |
| Debt/Equity Ratio | 36.6% |
How did STENO perform over the long term?
See historical performance and comparison